6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)

NCT00265343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: asenapine
DRUG: olanzapine

Sponsor

Organon and Co